Feasibility of the ACL (albumin, C-reactive protein and lactate dehydrogenase) model as a novel prognostic tool in patients with metastatic renal cell carcinoma previously receiving first-line targeted therapy-Reference-Cited by-同舟云学术

Feasibility of the ACL (albumin, C-reactive protein and lactate dehydrogenase) model as a novel prognostic tool in patients with metastatic renal cell carcinoma previously receiving first-line targeted therapy

Published:2020-01 Issue:1 Volume:38 Page:6.e9-6.e16
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Tamura Keita,Matsushita Yuto,Watanabe Hiromitsu,Motoyama Daisuke,Ito Toshiki,Sugiyama Takayuki,Otsuka Atsushi,Miyake Hideaki

Funder

School of Medicine

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference24 articles.

1. Systemic therapy in metastatic renal cell carcinoma;Bedke;World J Urol,2017

2. Immune checkpoint inhibitors: toward new paradigms in renal cell carcinoma;Flippot;Drugs,2018

3. What is the optimal therapy for patients with metastatic renal cell carcinoma who progress on an initial VEGFr-TKI?;Calvo;Cancer Treat Rev,2013

4. Prognostic factors and prognostic models for renal cell carcinoma: a literature review;Klatte;World J Urol,2018

5. Early tumor shrinkage under treatment with first-line tyrosine kinase inhibitors as a predictor of overall survival in patients with metastatic renal cell carcinoma: a retrospective multi-institutional study in Japan;Miyake;Target Oncol,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs;Cells;2022-09-23

2. Long-term outcome of renal cell carcinoma in patients with HIV who undergo surgery;BMC Infectious Diseases;2022-07-09

3. Assessment of prognostic factors in previously treated Japanese patients with metastatic renal cell carcinoma who received nivolumab: An observational multi‑institute study;Molecular and Clinical Oncology;2021-11-21

4. The Role of C-Reactive Protein in Kidney, Bladder, and Prostate Cancers;Frontiers in Immunology;2021-08-27

5. External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohort;Japanese Journal of Clinical Oncology;2021-01-22